Publicaciones en colaboración con investigadores/as de Hospital de Cabueñes (17)

2016

  1. Inflammatory-related genetic variants in non-muscle-invasive bladder cancer prognosis: A multimarker bayesian assessment

    Cancer Epidemiology Biomarkers and Prevention, Vol. 25, Núm. 7, pp. 1144-1150

  2. Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models

    BMC Cancer, Vol. 16, Núm. 1

2013

  1. Lung cancer risk associated with residential proximity to industrial installations: A spatial analysis

    International Journal of Environmental Science and Technology, Vol. 10, Núm. 5, pp. 891-902

2012

  1. Association of p21 Ser31Arg and p53 Arg72Pro polymorphisms with lung cancer risk in CAPUA study

    Lung Cancer: Targets and Therapy, Vol. 3, pp. 69-78

  2. Genetic polymorphisms in CYP1A1, GSTM1, GSTP1 and GSTT1 metabolic genes and risk of lung cancer in Asturias

    BMC Cancer, Vol. 12

  3. Genetic polymorphisms in MMP 2, 9 and 3 genes modify lung cancer risk and survival

    BMC Cancer, Vol. 12

  4. The value of plasmatic determination of matrix metalloproteinase 9 as a diagnostic marker in prostate cancer. Closing the controversies

    EUROPEAN UROLOGY SUPPLEMENTS

2010

  1. Expresión de metaloproteasa de matriz 9 en el cáncer de próstata. Experiencia preliminar

    Archivos Espanoles de Urologia, Vol. 63, Núm. 2, pp. 119-124

  2. Polimorfismos de la metaloproteasa de matriz 9 (MMP-9) en el diagnóstico del carcinoma prostático. Experiencia preliminar

    Archivos Espanoles de Urologia, Vol. 63, Núm. 2, pp. 125-132

  3. THE EFFECTS OF URINARION FREQUENCY, WATER INTAKE AND SMOKING STATUS ON BLADDER CANCER RISK

    EUROPEAN UROLOGY SUPPLEMENTS

2009

  1. TOTAL FLUID AND WATER CONSUMPTION AND THE JOINT EFFECT OF EXPOSURE TO DISINFECTION BY-PRODUCTS ON RISK OF BLADDER CANCER

    EUROPEAN UROLOGY SUPPLEMENTS

2008

  1. Polymorphism +17 C/G in Matrix Metalloprotease MMP8 decreases lung cancer risk

    BMC Cancer, Vol. 8

  2. The TP53 Arg72Pro polymorphism and lung cancer risk in a population of Northern Spain

    Lung Cancer, Vol. 61, Núm. 3, pp. 309-316

2007

  1. Influencia de los polimorfismos en genes de metabolización de carcinógenos y riesgo de cáncer de pulmón

    Mapfre Medicina, Vol. 18, Núm. 4, pp. 292-304

  2. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of Northern Spain

    BMC Cancer, Vol. 7

2004

  1. Poly (AT) polymorphism in intron 11 of the XPC DNA repair gene enhances the risk of lung cancer

    Cancer Epidemiology Biomarkers and Prevention, Vol. 13, Núm. 11, pp. 1788-1793

2000

  1. Análisis de ploidía de ADN y fases del ciclo celular por citometría de flujo en el lavado vesical. Experiencia preliminar

    Archivos Espanoles de Urologia, Vol. 53, Núm. 1, pp. 29-36